Ziemer product profile
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Perfuse Therapeutics shares findings from glaucoma and diabetic retinopathy trials of PER-001
Phil Lai, MD, chief medical officer of Perfuse Therapeutics, said the company's goal is to pioneer disease-modifying treatment that targets an underlying pathology of ischemia
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Nationwide free transport for cataract patients through SpaMedica
SpaMedica to offer free transport for all NHS cataract patients, supporting community care and reducing health inequalities.
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Heidelberg Engineering launches ZinserLab innovation hub, expands Orbis collaboration
The imaging innovation project is named after the company's cofounder Gerhard Zinser, PhD
Long-duration spaceflight tests the limits of telemedicine
In-orbit imaging drives innovation in terrestrial telemedicine, the NASA scientist explained